Tachycardia
Reports summarize tachycardia study results from University of Tokyo, Faculty of Medicine
Published in Cardiovascular Business Week, June 5th, 2007
Research findings, "Age and sex-related differences in dose-dependent hemodynamic response to landiolol hydrochloride during general anesthesia," are discussed in a new report. "Landiolol hydrochloride is a new ultra-short-acting beta(1)-adrenergic receptor blocking agent that is used for patients with tachycardia during general anesthesia. The hemodynamic response to a beta-adrenergic receptor blocking agent is generally dependent on the subject," scientists in Tokyo, Japan report.
"In the present investigation we investigated the effects of age and sex on the hemodynamic response to different doses of landiolol. Following a persistence of tachycardia for more than 1...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Cardiology
Cook Vascular Launches BULLDOG Lead Extender - Cardiology
Corgenix to Exhibit at American College of Cardiology 2007 - Cardiology
Medtronic Names David Etzwiler Executive Director of the Medtronic Foundation - Cardiology
Missouri Baptist Medical Center Named Missouri's Top Hospital for Cardiac Care - Cardiology
TomTec launches MRI technology - Clinical Research
AtCor Medical and Encorium Group, Inc. Broaden Market Reach with Alliance for Clinical Research Trials - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
